Clinical Trials Logo

Disease clinical trials

View clinical trials related to Disease.

Filter by:

NCT ID: NCT03528096 Completed - Clinical trials for Sleep Related Rhythmic Movement Disorder (Disorder)

Vestibular Stimulation Therapy for Rhythmic Movement Disorder

Start date: March 30, 2018
Phase: N/A
Study type: Interventional

This study aims to a) investigate the feasibility of the detection of episodes of RMD using contactless 3D video analysis and customised analysis software and b) the use of vestibular stimulation as a therapy for childhood rhythmic movement disorder.

NCT ID: NCT03522844 Completed - Anxiety Disorders Clinical Trials

Treatments for Anxiety: Meditation and Escitalopram

TAME
Start date: June 18, 2018
Phase: Phase 4
Study type: Interventional

We propose the first randomized, controlled study to assess the comparative effectiveness of Mindfulness-Based Stress Reduction (MBSR) with a medication for anxiety disorders. We will use escitalopram, gold-standard SSRI treatment for patients with anxiety disorders, and will examine the comparative effectiveness of the two treatments on anxiety symptoms and other outcomes important to patients.

NCT ID: NCT03522337 Completed - Epilepsy Clinical Trials

Oral Health Promotion Among Preschool Children With Special Needs

Start date: April 12, 2016
Phase: N/A
Study type: Interventional

Establishing good oral health-related habit is challenging among younger children, especially for preschool children with special needs, as they have physical, mental, sensory, behavioural, emotional, and chronic medical conditions that requires health care beyond the routines. Existing evidences showed that children with special needs have poorer oral health status and more challenging behaviours than their counterparts in main stream schools. Visual pedagogy, such as social stories, have been applied to teach a variety of skills or behaviours to individuals with special needs. They are short stories demonstrating the target skill or behaviour, and then the readers are expected to perform the target skill or behaviour following the demonstrations. Giving the evidence that children with special needs can understand complex situations and learn new practices by using those stories, we expect to apply a package of structured social stories to modify oral health-related behaviours (tooth brushing, healthy eating, dental visit), and thereby, improve oral health status among preschool children with special needs. Establishment of good oral-health related behaviours in early childhood will benefits children in their future life. Additionally, visual pedagogy-assisted oral health education is relatively easy and safe to implement. If proven effective, social story-based preventive care can be recommended to special children globally.

NCT ID: NCT03521609 Enrolling by invitation - Clinical trials for Substance Use Disorders

Emotional Intelligence in Patients With Addictive Disorder

Start date: May 25, 2018
Phase: N/A
Study type: Interventional

The study aims to evaluate the level of emotional intelligence in patients diagnosed with substance use disorder and to evaluate the benefits in emotional skills after a brief intervention based on emotional intelligence.

NCT ID: NCT03519035 Not yet recruiting - Clinical trials for Borderline Personality Disorder

Study of Hallucinations in Patients With Borderline Personality Disorder

Start date: July 2018
Phase:
Study type: Observational [Patient Registry]

Hallucinations in borderline personality disorder are a frequent an serious trouble which have an important impact in patients lives. Despite this, they are often ignored by nursing staff, and are not an important criteria in Diagnostic and Statistical Manual (DSM) 5 and Classification Internationale des maladies (CIM-10). The main objective of our study is to assess the prevalence of this trouble in borderline personality disorder (BPD) population, and to characterize the hallucinations in order to compare our results with those of international studies.

NCT ID: NCT03517878 Completed - Depression Clinical Trials

Evaluation of a Home-based Community Health Worker Program in Rural Eastern Cape, South Africa

Start date: August 11, 2014
Phase:
Study type: Observational

The purpose of this early Phase 2 comparison trial is to evaluate the impact of community health worker (CHW) home visitors on pregnant women and their children in a rural setting in the rural Eastern Cape of South Africa. The intervention provided by the CHWs targets underweight children, mothers living with HIV (MLH), mothers using alcohol, and depressed mothers with the goal of supporting pregnant women to improve birth outcomes, decrease the number of children born with a low birthweight, and develop child caretaking skills over time. UCLA has identified and matched four areas surrounding primary health care clinics: two intervention areas in which this CHW program has been running for one year, and two control areas without the program. Mothers in the research area are followed for one year after giving birth.

NCT ID: NCT03514810 Completed - Clinical trials for Major Depressive Disorder

Combined Sertraline and Ketoprofen Administration in Major Depressive Disorder

Srt+ktpMDD
Start date: January 10, 2017
Phase: Phase 1
Study type: Interventional

Among the major depressive disorder (MDD) patients in the follow-up group, 16 were administered with 50 mg of oral sertralin once daily with placebo, whereas 28 were treated with 100 mg of ketoprofen once daily as adjuvant treatment for MDD. Controls do not take any medicine.

NCT ID: NCT03510741 Completed - Schizophrenia Clinical Trials

Sodium Benzoate and/or N-Acetylcysteine Added to TAU in Patients With Early Schizophrenia Spectrum Disorder.

Start date: January 1, 2019
Phase: Phase 2
Study type: Interventional

This study aims to determine if the addition of Sodium Benzoate and / or NAC to TAU will be acceptable and tolerable and result in overall improvement of symptoms, social and cognitive functioning in patients with early schizophrenia spectrum disorder.

NCT ID: NCT03510533 Not yet recruiting - Eating Disorder Clinical Trials

Validation of the Concept of the Autoantibodies Directed Against the Neuropeptides Involved in Food Intake Regulation on the Incidental Cases of Eating Disorders

EDILS-AutoAC
Start date: May 2018
Phase: N/A
Study type: Interventional

This study should lead to the validation of the concept of the autoAc directed against the neuropeptides involved in food intake regulation.

NCT ID: NCT03507985 Not yet recruiting - Memory Disorders Clinical Trials

Attention and Memory Disorders Related to Acute Morphine

MEMOMORPH
Start date: September 2018
Phase:
Study type: Observational

The aim of the study is to determine if there are attention disorders related to acute morphine use in single-traumatized patients and after that the investigators will determine whether there are immediate memory problems associated with acute morphine withdrawal in single-traumatized patients. From a biochemical point of view, the analgesic effects of morphine and the central side effects appear to be two different dimensions of the action of morphine, each related to a metabolite. Regarding acute attention, it is difficult to differentiate attention deficit disorder due to pain or due to morphine. Two tests have been validated in the literature to evaluate attention and memory: the 15 words of Rey and the Stroop Color Word test. The investigators will use these two tests in this study.